Commentary
Podcast
A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).
Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF).
In this podcast, you’ll hear insight from the following individuals:
These experts discuss what IPF is, how it impacts patients’ quality of life, barriers to care, and treatments in the pipeline.
Listen above or through one of these podcast services:
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.